Do essential fatty acids have a role in the treatment of depression? 2006

Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
Yale Prevention Research Center, 130 Division Street, Derby, CT 06418, USA.

BACKGROUND Complementary and alternative medicine (CAM) therapies are used more than conventional therapies by people with self-defined anxiety and depression. Preliminary evidence supports a hypothesis that low plasma concentration of essential fatty acids is associated with depression. Reported here is the result of a systematic review examining the therapeutic efficacy of essential fatty acids for depression. METHODS Data sources included Medline, Psychinfo, AMED (Allied and Complementary Medicine), and Cochrane Controlled Trials Register databases searched from inception through September 2001. English language randomized controlled trials, controlled clinical trials, intervention studies, case control studies, reviews, and case reports of humans were selected, without limits for demographics or co-morbidities. Two abstractors independently evaluated each study, then reconciled findings. When possible, between group treatment effect size was noted or calculated. RESULTS Six articles met inclusion criteria: one RCT, two reviews, and three case control trials. A common outcome measure among the case control trials allowed for direct comparison of effect sizes. CONCLUSIONS The evidence implies promise of a treatment effect of omega-3 fatty acids for depression in adults; although a statement of definitive clinical efficacy is premature. Further study of essential fatty acids as independent and adjuvant therapy for adult depression is indicated, including more sophisticated investigation of dose-response in particular populations.

UI MeSH Term Description Entries

Related Publications

Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
August 2006, Neuro endocrinology letters,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
January 1992, Neuroscience and biobehavioral reviews,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
January 2012, Frontiers in physiology,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
March 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
October 2003, Journal of psychosocial nursing and mental health services,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
November 2002, Prostaglandins, leukotrienes, and essential fatty acids,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
January 2005, Annual review of nutrition,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
October 2004, Prostaglandins, leukotrienes, and essential fatty acids,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
April 2010, Acta psychiatrica Scandinavica,
Anna-leila Williams, and David Katz, and Ather Ali, and Christine Girard, and Jonathan Goodman, and Iris Bell
February 2007, Drug and therapeutics bulletin,
Copied contents to your clipboard!